Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-3587
Title: In vitro characterization of a new composite material for biomedical applications and 3D (bio)printing
Authors : Bono, Epifania
Evers, Christoph
Schmid, Franca
Graf-Hausner, Ursula
Rimann, Markus
Conference details: TEDD Annual Meeting, Waedenswil, November 8-9 2017
Publisher / Ed. Institution : Zürcher Hochschule für Angewandte Wissenschaften
Issue Date: Nov-2017
License (according to publishing contract) : Licence according to publishing contract
Type of review: Not specified
Language : English
Subject (DDC) : 540: Chemistry
570: Biology
Abstract: Study goal The present project aims at evaluating the cytocompatibility and printability of a new composite material, based on a mixture of a new methacrylate-based monomer developed within a CTI project (18514.1 PFLS-LS) and glass-ceramic powder supplemented with co- and photo-initiators (patent in preparation). This study is the basis to demonstrate the suitability of the biomaterial, for biomedical applications, such as stent, orthopedic implants and hearing aid components, as well as for 3D (bio)printing Key findings - Cultivation, proliferation and differentiation of three different human cell types were successfully established on composite material discs (1cm diameter, 1mm height). Biological activity was shown - The material is suitable for 3D (bio)printing, printing protocols were established - The new composite material is suitable for cell and tissue interaction in biomedical applications
Departement: Life Sciences und Facility Management
Organisational Unit: Institute of Chemistry and Biotechnology (ICBT)
Publication type: Conference Poster
DOI : 10.21256/zhaw-3587
URI: https://digitalcollection.zhaw.ch/handle/11475/5402
Appears in Collections:Publikationen Life Sciences und Facility Management

Files in This Item:
File Description SizeFormat 
Saremco Poster_TEDD AM 2017_final.pdf451.34 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.